What is the most recent earnings date for STOK stock?
STOKE THERAPEUTICS INC (STOK) last reported earnings on 1/12/2026.
STOKE THERAPEUTICS INC (STOK) Earnings History & Surprises
NASDAQ:STOK • US86150R1077
Current stock price
32.56 USD
+0.79 (+2.49%)
At close:
33 USD
+0.44 (+1.35%)
After Hours:
STOK Earnings overview
Past quarterly earnings results for STOKE THERAPEUTICS INC (STOK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.84
- Revenue Estimate
- 6.457M
Last Reported
Most Recent- Release Date
- Jan 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.97
- EPS Surprise
- -33.26%
- Revenue Surprise
- -76.63%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.97 | -0.73 | -33.26% | -438.89% | 1.402M | 5.998M | -76.63% | -93.80% |
| Q3 2025 | -0.65 | -0.58 | -12.12% | -38.30% | 10.632M | 6.283M | 69.22% | 117.25% |
| Q2 2025 | -0.40 | -0.52 | 23.41% | 13.04% | 13.817M | 9.089M | 52.02% | 186.01% |
| Q1 2025 | 1.98 | -0.43 | 558.67% | 447.37% | 158.569M | 8.938M | 1,674.10% | 3,661.12% |
| Q4 2024 | -0.18 | -0.54 | 66.58% | 70.00% | 22.614M | 4.366M | 417.96% | 707.35% |
| Q3 2024 | -0.47 | -0.54 | 13.51% | 15.16% | 4.894M | 3.417M | 43.23% | 47.94% |
| Q2 2024 | -0.46 | -0.57 | 19.47% | 33.33% | 4.831M | 3.321M | 45.47% | 294.72% |
| Q1 2024 | -0.57 | -0.62 | 8.39% | -7.55% | 4.216M | 3.279M | 28.58% | -18.17% |
| Q4 2023 | -0.60 | -0.64 | 6.63% | 7.69% | 2.801M | 3.315M | -15.51% | -14.34% |
| Q3 2023 | -0.55 | -0.65 | 14.13% | 16.06% | 3.308M | 3.251M | 1.75% | 13.68% |
| Q2 2023 | -0.69 | -0.65 | -6.31% | -9.52% | -2.481M | 3.162M | -178.46% | -176.81% |
| Q1 2023 | -0.53 | -0.71 | 25.38% | 19.70% | 5.152M | 2.678M | 92.38% | 71.73% |
| Q4 2022 | -0.65 | -0.72 | 9.22% | 1.52% | 3.27M | 2.628M | 24.43% | - |
| Q3 2022 | -0.66 | -0.70 | 5.40% | -8.20% | 2.91M | 2.499M | 16.45% | - |
| Q2 2022 | -0.63 | -0.70 | 10.20% | -5.00% | 3.23M | 2.394M | 34.92% | - |
| Q1 2022 | -0.66 | 0.37 | -278.64% | -43.48% | 3M | 40.8M | -92.65% | - |
| Q4 2021 | -0.66 | -0.64 | -3.86% | -57.14% | - | - | ||
| Q3 2021 | -0.61 | -0.60 | -1.75% | -48.78% | - | - | ||
| Q2 2021 | -0.60 | -0.48 | -25.16% | -53.85% | - | - | ||
| Q1 2021 | -0.46 | -0.45 | -2.50% | -35.29% | - | - | ||
| Q4 2020 | -0.42 | -0.43 | 1.73% | - | - | - | ||
| Q3 2020 | -0.41 | -0.42 | 2.96% | - | - | - | ||
| Q2 2020 | -0.39 | -0.36 | -7.81% | - | - | - | ||
| Q1 2020 | -0.34 | -0.36 | 6.40% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
159.13%
Max EPS beat (4)
558.67%
Min EPS beat (4)
-12.12%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
553.32%
Max Revenue beat (4)
1,674.10%
Min Revenue beat (4)
52.02%
Analysis
In the last 4 quarters, STOK has beaten EPS estimates in 3 out of 4 releases
STOK has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, STOK has beaten the EPS estimates by 159.1% on average.
In the last 4 quarters, STOK has beaten the revenue estimates by 553.3% on average.
Related analysis
STOKE THERAPEUTICS INC / STOK Earnings FAQ
Can you provide information on whether STOKE THERAPEUTICS INC beat earnings estimates in the last quarter?
STOKE THERAPEUTICS INC (STOK) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does STOK stock beat earnings estimates?
In the last 4 quarters, STOKE THERAPEUTICS INC (STOK) has beaten EPS estimates in 3 out of 4 releases.